PetIQ Inc
NASDAQ:PETQ
PetIQ Inc
NASDAQ:PETQ
Price:
17.04 USD
1.19%
Market Closed
Updated:
May 5, 2024
P/E
Price to Earnings
Price to Earnings
235.3
Current
-12.2
Median
23.4
Industry
Higher
than median
Higher
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=235.3
Market Cap
/
501.5m
Net Income
2.1m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
PetIQ Inc
NASDAQ:PETQ
|
501.5m USD | 235.3 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
69.3B USD | 23.1 | |
| US |
|
Cencora Inc
NYSE:COR
|
44.7B USD | 24.1 | |
| US |
|
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 20.9 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
24.1B USD | 37.8 | |
| KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 89.6 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.8B USD | 21.1 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
57.6B CNY | 21.3 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
61.2B HKD | 6.4 | |
| IT |
|
Amplifon SpA
MIL:AMP
|
7.1B EUR | 45.9 | |
| CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51B CNY | 13.5 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
13
2-Years Forward
P/E
10.7
3-Years Forward
P/E
8.4
You don't have any saved screeners yet
